Related Experiment Video
Updated: Mar 8, 2026
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
778
Caring for Young Children Exposed to Marijuana
Natasha M Ruiz1, Susan E Shapiro
1Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
Advanced Emergency Nursing Journal
|February 1, 2017
Summary
Marijuana exposure in children is rising, particularly in states with legalized marijuana. Advanced practice registered nurses must be prepared to manage pediatric marijuana intoxication and educate families on prevention.
Area of Science:
- Pediatric Toxicology
- Public Health
- Nursing Practice
Background:
- Marijuana legalization is expanding nationwide.
- Increased availability correlates with higher exposure risks for children.
- Pediatric marijuana exposure presents unique clinical challenges.
Purpose of the Study:
- To review trends in pediatric marijuana exposure.
- To inform advanced practice registered nurses (APRNs) on managing these cases.
- To emphasize the role of APRNs in child safety and education.
Main Methods:
- Review of a research report on pediatric marijuana exposure.
- Analysis of data from the National Poison Data System.
- Application of findings to the practice of advanced practice registered nurses.
Main Results:
- A significant increasing trend in marijuana exposure among children under six years old was identified.
- This trend is more pronounced in states with legalized medical or recreational marijuana.
- Case study approach highlights the relevance for advanced practice registered nurses.
Conclusions:
- Advanced practice registered nurses require enhanced knowledge of pediatric marijuana intoxication.
- Nurses play a crucial role in recognizing and managing marijuana exposure in children.
- Parental education on creating safe environments is essential for preventing exposure.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
872
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
872
01:29Drug Dosing: Infants and Children
625
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
01:21Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
1.4K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
1.4K